论文部分内容阅读
近十年间，江西东亚药业有限责任公司产值和利税平均每年分别以 35％和 16％的速度递增，“九五”期末该公司工业总产值已达 3亿元，利税超千万元，输液年产量 6000万瓶，成为江西省最大的输液生产基地，并跻身全国输液制药企业“三甲”行列。东亚公司创造了奇迹般的发展速度，
In the past ten years, the output value and profits and taxes of Jiangxi East Asia Pharmaceutical Co., Ltd. increased by 35% and 16% respectively on average respectively. At the end of the Ninth Five-year Plan period, the total industrial output value of the company reached 300 million yuan, the profit and tax exceeded 10 million yuan, Annual output 60 million bottles, becoming the largest infusion production base in Jiangxi Province, and ranks among the infusion pharmaceutical companies in the “top three” ranks. East Asian companies have created a miraculous pace of development,